Authors: Burstein, HJ Kuter, I Campos, SM Gelman, RS Tribou, L Parker, LM Manola, J Younger, J Matulonis, U Bunnell, CA Partridge, AH Richardson, PG Clarke, K Shulman, LN Winer, EP

Citation: Hj. Burstein et al., Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer, J CL ONCOL, 19(10), 2001, pp. 2722-2730

Authors: Schenkein, DP Koc, Y Alcindor, T Stadtmauer, EA Miller, KB Cooper, BW Partridge, AH Lazarus, HM

Citation: Dp. Schenkein et al., Treatment of primary resistant or relapsed multiple myeloma with high-dosechemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factor, BIOL BLOOD, 6(4A), 2000, pp. 448-455

Authors: Partridge, AH Garber, JE

Citation: Ah. Partridge et Je. Garber, Long-term outcomes of children exposed to antineoplastic agents in utero, SEMIN ONCOL, 27(6), 2000, pp. 712-726